125 related articles for article (PubMed ID: 3762184)
1. Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature.
Edington H; Salwitz J; Longo DL; Roth JA; Pass H
J Surg Oncol; 1986 Oct; 33(2):120-3. PubMed ID: 3762184
[TBL] [Abstract][Full Text] [Related]
2. Mediastinal Hodgkin's disease. Significance of mediastinal involvement in early stage Hodgkin's disease.
Mauch P; Hellman S
Hematol Oncol; 1984; 2(1):69-72. PubMed ID: 6547403
[No Abstract] [Full Text] [Related]
3. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Zhen ZJ; Sun XF; Xia Y; Wang ZH; Ling JY
Ai Zheng; 2006 Apr; 25(4):471-5. PubMed ID: 16613683
[TBL] [Abstract][Full Text] [Related]
4. [Diffuse thymus hyperplasia following chemotherapy for nodular sclerosing Hodgkin lymphoma].
Hermann R; Greminger P; Dommann-Scherrer C; Krestin GP; Stahel R
Schweiz Med Wochenschr; 1994 Sep; 124(38):1666-71. PubMed ID: 7524146
[TBL] [Abstract][Full Text] [Related]
5. Combined modality (ABVD plus radiotherapy) versus radiotherapy in the management of early stage (IIA) Hodgkin's disease with mediastinal involvement.
Anselmo AP; Bove M; Cartoni C; Damico C; Maurizi Enrici R; Falchetto Osti M; Biagini C
Haematologica; 1992; 77(2):177-9. PubMed ID: 1383107
[TBL] [Abstract][Full Text] [Related]
6. Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission.
Langer CJ; Keller SM; Erner SM
Cancer; 1992 Oct; 70(8):2082-6. PubMed ID: 1382826
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Preti A; Hagemeister FB; McLaughlin P; Swan F; Rodriguez A; Besa P; Cox JD; Allen PK; Cabanillas F
Ann Oncol; 1994; 5 Suppl 2():97-100. PubMed ID: 7515653
[TBL] [Abstract][Full Text] [Related]
8. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G;
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169
[TBL] [Abstract][Full Text] [Related]
9. [Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].
Błasińska-Morawiec M; Płuzańska A; Krykowski E; Robak T; Mrówka I
Pol Arch Med Wewn; 1991 Oct; 86(4):274-80. PubMed ID: 1813880
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of large mediastinal involvement in Hodgkin's disease.
Mazza P; Lauria F; Sciascia R; Emiliani E; Fiacchini M; Baccarani M; Frezza G; Dominici G; Cantore M; Faedi M
Scand J Haematol; 1983 Oct; 31(4):315-21. PubMed ID: 6688679
[TBL] [Abstract][Full Text] [Related]
11. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
12. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's disease, intracranial involvement. Report of a case and review of the literature.
Vera R; Enriquez R; Papac R
Am J Clin Oncol; 1985 Feb; 8(1):73-6. PubMed ID: 3838852
[TBL] [Abstract][Full Text] [Related]
14. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S
Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778
[No Abstract] [Full Text] [Related]
15. Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
Elconin JH; Roberts KB; Rizzieri DA; Vermont C; Clough RW; Kim C; Dodge RK; Prosnitz LR
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1097-105. PubMed ID: 11072168
[TBL] [Abstract][Full Text] [Related]
16. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
[No Abstract] [Full Text] [Related]
17. Supradiaphragmatic Hodgkin's disease: is there a role for MOPP chemotherapy in patients with bulky mediastinal disease?
Mauch P; Hellman S
Int J Radiat Oncol Biol Phys; 1980 Jul; 6(7):947-9. PubMed ID: 7204134
[No Abstract] [Full Text] [Related]
18. Thymic epithelial hyperplasia with nodular sclerosis Hodgkin's disease.
Ito W; Kojima K; Fujiwara K; Nanba Y; Yoshino T; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Tanimoto M
Leuk Lymphoma; 2002 Nov; 43(11):2229-31. PubMed ID: 12533053
[TBL] [Abstract][Full Text] [Related]
19. Thymic hyperplasia following successful treatment for nodular-sclerosing Hodgkin's disease.
Scheinpflug K; Schmitt J; Jentsch-Ullrich K; Roessner A; Franke A
Leuk Lymphoma; 2003 Sep; 44(9):1615-7. PubMed ID: 14565667
[TBL] [Abstract][Full Text] [Related]
20. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
